Приказ основних података о документу

dc.creatorĐurković-Đaković, Olgica
dc.creatorKlun, Ivana
dc.creatorKhan, Asis
dc.creatorNikolić, Aleksandra
dc.creatorKnežević-Usaj, Slavica
dc.creatorBobić, Branko
dc.creatorSibley, L. David
dc.date.accessioned2021-04-20T12:11:35Z
dc.date.available2021-04-20T12:11:35Z
dc.date.issued2006
dc.identifier.issn1286-4579
dc.identifier.urihttp://rimi.imi.bg.ac.rs/handle/123456789/152
dc.description.abstractDespite its capacity for sexual reproduction and global distribution, Toxoplasma gondii has a highly clonal structure, with the majority of isolates belonging to three distinct clonal types. Congenital toxoplasmosis has been associated with type I and type II strains. We here present the first characterization of a T. gondii strain (BGD1) from South-East Europe, isolated from the umbilical blood of a 24-week-old fetus in Serbia. Genotyping, performed by PCR-RFLP using a set of nested PCR markers (5'SAG2, 3'SAG2, BTUB, SAG3, and GRA6), showed that the BGD1 strain possessed a type II genotype. The cytokine patterns in Swiss-Webster mice inoculated with brain cysts of BGD1 and the prototype type II ME49 strain were similar until 180 days post-infection, with highly elevated IFN-gamma, IL-12 and IL-10 by d7 and decreasing thereafter. While both strains induced pneumonia and hepatitis in acute infection (d14), chronic infection (d56) was characterized, in addition to hepatitis, by severe meningoencephalitis, associated with numerous brain cysts. Thus, the BGD1 strain of T. gondii has type II genotypic and immunologic characteristics, but unlike other type II strains of human origin, induces severe encephalitis, making it an alternative to the sheep-derived ME49 strain for experimental models of infection.en
dc.publisherElsevier Science Bv, Amsterdam
dc.relationUnited States Department of Health & Human Services, National Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [AI059176, R01 AI059176] Funding Source: Medline
dc.relationUnited States Department of Health & Human Services, National Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI059176, R01AI059176, R01AI059176, R01AI0
dc.rightsrestrictedAccess
dc.sourceMicrobes & Infection
dc.subjectToxoplasma gondiien
dc.subjectcongenital toxoplasmosisen
dc.subjectgenotypingen
dc.subjectPCR-RFLPen
dc.subjecttype II strainsen
dc.subjectmurine infectionen
dc.subjectcytokinesen
dc.subjecthistopathologyen
dc.titleA human origin type II strain of Toxoplasma gondii causing severe encephalitis in miceen
dc.typearticle
dc.rights.licenseARR
dc.citation.epage2212
dc.citation.issue8
dc.citation.other8(8): 2206-2212
dc.citation.rankM22
dc.citation.spage2206
dc.citation.volume8
dc.identifier.doi10.1016/j.micinf.2006.04.016
dc.identifier.pmid16797199
dc.identifier.scopus2-s2.0-33748208159
dc.identifier.wos000241115100027
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу